119-sres464

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 464 Agreed to Senate

    (ATS) ]

<DOC>

119th CONGRESS
 1st Session
S. RES. 464

Designating September 2025 as ``National Cholesterol Education Month'' 
 and September 30, 2025, as ``LDL-C Awareness Day''.

_______________________________________________________________________

 IN THE SENATE OF THE UNITED STATES

 October 23, 2025

 Mrs. Hyde-Smith (for herself, Mr. Peters, Mr. Boozman, Mr. Marshall, 
Mr. Daines, and Mr. Padilla) submitted the following resolution; which 
 was considered and agreed to

_______________________________________________________________________

 RESOLUTION

Designating September 2025 as ``National Cholesterol Education Month'' 
 and September 30, 2025, as ``LDL-C Awareness Day''.

Whereas cardiovascular disease is the leading cause of death for men and women 
 in the United States;
Whereas projected rates of cardiovascular disease are expected to increase 
 significantly in the United States by 2060;
Whereas, compared to urban areas, rural areas in the United States have higher 
 death rates for cardiovascular disease and stroke, and a 40 percent 
 higher prevalence of cardiovascular disease;
Whereas risk factors contributing to cardiovascular disease and poor health 
 outcomes include elevated low density lipoprotein cholesterol (referred 
 to in this preamble as ``LDL-C''), high levels of lipoprotein

    (a) cholesterol, hypertension, obesity, low awareness of personal risk 
 factors, genetics, geographic location, and inequitable access to care;
Whereas lipoprotein

    (a) cholesterol is predominantly genetically inherited and 
 can build up in the walls of blood vessels, creating cholesterol 
 deposits, or plaques, and lead to atherosclerotic cardiovascular 
 disease;
Whereas LDL-C is a modifiable risk factor for cardiovascular disease, and having 
 lower LDL-C is associated with a reduced risk of heart attack and 
 stroke;
Whereas more than 25.5 percent of adults in the United States have high LDL-C;
Whereas more than 200 studies with more than 2,000,000 patients have broadly 
 established that elevated LDL-C causes atherosclerotic cardiovascular 
 disease;
Whereas atherosclerotic cardiovascular disease is the build-up of cholesterol 
 plaque within the walls of arteries and includes acute coronary 
 syndrome, peripheral arterial disease, and events such as heart attacks 
 and strokes;
Whereas the resources needed to bend the curve on cardiovascular disease exist, 
 yet 71 percent of hypercholesterolemia patients at high risk of a 
 cardiovascular event never achieve recommended LDL-C treatment guideline 
 thresholds;
Whereas only 33 percent of individuals with atherosclerotic cardiovascular 
 disease who are taking statins, a guideline recommended lipid-lowering 
 therapy, actually achieve LDL-C goals;
Whereas, although clinical guidelines recommend that a patient hospitalized for 
 heart attack receive an LDL-C test in the 90 days following discharge 
 from a hospital, only 27 percent of patients receive the test;
Whereas African-American adults are less likely to receive an LDL-C test in the 
 90 days following discharge from a hospital, despite having a higher 
 prevalence of cardiovascular disease;
Whereas significant gaps in care may lead to subsequent cardiovascular events;
Whereas the Million Hearts program seeks to improve access to and quality of 
 care to reduce heart disease, stroke, and death; and
Whereas September is recognized as National Cholesterol Education Month to raise 
 awareness of cardiovascular disease and the importance of individuals 
 knowing their LDL-C number: Now, therefore, be it
 Resolved, That the Senate--

    (1) encourages all individuals in the United States to know 
 their low density lipoprotein cholesterol (referred to in this 
 resolution as ``LDL-C'') number;

    (2) designates September 2025 as ``National Cholesterol 
 Education Month'';

    (3) designates September 30, 2025, as ``LDL-C Awareness 
 Day''; and

    (4) recognizes the urgent need for screening and treating 
 of elevated LDL-C to reduce the risk of cardiovascular disease 
 and cardiovascular events, including heart attacks and strokes.
 <all>